✦ LIBER ✦

Disappointing results for phase III semagacestat trial

Book ID: 125388714
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2013
Weight: 111 KB
Volume: 1473
Category: Article
ISSN: 0114-9954
DOI: 10.1007/s40278-013-6374-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluating semagacestat, a gamma-secreta

Evaluating semagacestat, a gamma-secretase inhibitor, in a phase III trial

✍ Siemers, Eric; Henley, David; Sundell, Karen; Sethuraman, Gopalan; Dean, Robert; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 64 KB

A Phase 3 Trial of Semagacestat for Trea

A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease

✍ Doody, Rachelle S.; Raman, Rema; Farlow, Martin; Iwatsubo, Takeshi; Vellas, Brun 📂 Article 📅 2013 🏛 Massachusetts Medical Society 🌐 English ⚖ 537 KB

Abetimus: encouraging preliminary phase

Abetimus: encouraging preliminary phase III trial results

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Using meta-analysis of Phase II trials t

Using meta-analysis of Phase II trials to predict Phase III trial results

✍ Danielle Burke,Lucinda Billingham,Alan Girling,Richard Riley 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 123 KB

Archimedes Pharma announces first positi

Archimedes Pharma announces first positive phase III clinical trial results for NasalFent®

✍ Michael Clark 📂 Article 📅 2009 🏛 Grupo Aran 🌐 Spanish ⚖ 168 KB

Results of phase II and phase III trials

Results of phase II and phase III trials with new aromatase inhibitors

✍ W. Jonat 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 864 KB